Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The study is designed as a Phase III, randomized, double-blind, multicenter, prospective,
comparative study of fluconazole versus voriconazole for the prevention of fungal infections
in allogeneic transplant recipients. Recipients will be stratified by center and donor type
(sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm
in a 1:1 ratio.
Phase:
Phase 3
Details
Lead Sponsor:
Medical College of Wisconsin
Collaborators:
Blood and Marrow Transplant Clinical Trials Network National Cancer Institute (NCI) National Heart, Lung, and Blood Institute (NHLBI) National Marrow Donor Program